1-3 of 3
Hisatomi Arima
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

1192-P: Dapagliflozin Reduces Intrahepatic Triglyceride Content in Japanese Patients with Type 2 Diabetes Treated with Oral Antidiabetic Agents: A Randomized, Clinical Trial

KATSUTARO MORINO, KEIKO KONDO, SACHIKO TANAKA, ITSUKO MIYAZAWA, KEIKO FUSE, SHOGO IDA, HISATOMI ARIMA, KATSUYUKI MIURA, NATSUKO OHASHI, SATOSHI UGI, HIROSHI MAEGAWA, SUMS-ADDIT-2 RESEARCH GROUP
Journal: Diabetes
Diabetes 2019;68(Supplement_1):1192-P
https://doi.org/10.2337/db19-1192-P
Published: 01 June 2019
View articletitled, 1192-P: Dapagliflozin Reduces Intrahepatic Triglyceride Content in Japanese Patients with Type 2 Diabetes Treated with Oral Antidiabetic Agents: A Randomized, Clinical Trial
Meeting Abstracts

Ipragliflozin, a SGLT2 Inhibitor, Reduced Body Weight and Fat Mass but Not Muscle Mass in Japanese Type 2 Diabetic Patients Treated with Insulin—A Randomized Clinical Trial

KATSUTARO MORINO, HIDEKA INOUE, KEIKO FUSE, SACHIKO TANAKA, KEIKO KONDO, HISATOMI ARIMA, KATSUYUKI MIURA, DAISUKE SATO, NATSUKO OHASHI, SHOGO IDA, ITSUKO MIYAZAWA, OSAMU SEKINE, SATOSHI UGI, HIROSHI MAEGAWA, SUMS-ADDIT-1 STUDY GROUP
Journal: Diabetes
Diabetes 2018;67(Supplement_1):1199-P
https://doi.org/10.2337/db18-1199-P
Published: 01 July 2018
View articletitled, Ipragliflozin, a SGLT2 Inhibitor, Reduced Body Weight and Fat Mass but Not Muscle Mass in Japanese Type 2 Diabetic Patients Treated with Insulin—A Randomized Clinical Trial
Journal Articles

Impact of Kir6.2 E23K Polymorphism on the Development of Type 2 Diabetes in a General Japanese Population : The Hisayama Study

Yasufumi Doi, Michiaki Kubo, Toshiharu Ninomiya, Koji Yonemoto, Masanori Iwase, Hisatomi Arima, Jun Hata, Yumihiro Tanizaki, Mitsuo Iida, Yutaka Kiyohara
Journal: Diabetes
Diabetes 2007;56(11):2829–2833
https://doi.org/10.2337/db07-1709
Published: 01 November 2007
View articletitled, Impact of Kir6.2 E23K Polymorphism on the Development of Type 2 Diabetes in a General Japanese Population : The Hisayama Study
Open the PDF for Impact of Kir6.2 E23K Polymorphism on the Development of Type 2 Diabetes in a General Japanese Population : The Hisayama Study in another window